Improving Yield and Specific Activity of Copper-67 at Brookhaven Linac Isotope Producer, invited

摘要

Radioisotope ~(67)Cu is considered one of the most promising isotopes for radioimmunotherapy (RIT) among beta emitters. A number of research groups performed targeting studies of different types of cancer with ~(67)Cu such as ovarian cancer, bladder cancer, lymphoma and found its nuclear and chemical properties highly suitable for these application.